Literature DB >> 22003648

Finding the optimal compression level for strain-encoded (SENC) breast MRI; simulations and phantom experiments.

Ahmed A Harouni1, Michael A Jacobs, Nael F Osman.   

Abstract

Breast cancer is the most common cancer among women and the second highest cause of cancer-related death. Diagnostic magnetic resonance imaging (MRI) is recommended to screen high-risk patients. Strain-Encoded (SENC) can improve MRI's specificity by detecting and differentiating masses according to their stiffness. Previous phantom and ex-vivo studies have utilized SENC to detect cancerous masses. However, SENC required a 30% compression of the tissue, which may not be feasible for in-vivo imaging. In this work, we use finite element method simulations and phantom experiments to determine the minimum compression required to detect and classify masses. Results show that SENC is capable of detecting stiff masses at compression level of 7%, though higher compression is needed in order to differentiate between normal tissue and benign or malignant masses. With on-line SENC calculations implemented on the scanner console, we propose to start with small compressions for maximum patient comfort, then progress to larger compressions if any masses are detected.

Entities:  

Mesh:

Year:  2011        PMID: 22003648     DOI: 10.1007/978-3-642-23623-5_56

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  2 in total

1.  Assessment of liver fibrosis using fast strain-encoded MRI driven by inherent cardiac motion.

Authors:  Ahmed A Harouni; Ahmed M Gharib; Nael F Osman; Caryn Morse; Theo Heller; Khaled Z Abd-Elmoniem
Journal:  Magn Reson Med       Date:  2014-07-31       Impact factor: 4.668

2.  Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation.

Authors:  Grigorios Korosoglou; Sorin Giusca; Nina P Hofmann; Amit R Patel; Tomas Lapinskas; Burkert Pieske; Henning Steen; Hugo A Katus; Sebastian Kelle
Journal:  ESC Heart Fail       Date:  2019-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.